Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERON PHARMACEUTICALS Key Ratios

  • Valuation Ratio: REGN

    P/E (TTM) -17.49
    Price to CashFlow -71.31
    Price to Sales (TTM) 6.07
    Price to Book 3.68
  • Per Share Ratio: REGN

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 4.85
    EPS Fully Diluted -1.05
    Revenue Per Share 3.03
  • 5 Year Annual Growth: REGN

    Net Income
    Revenue 32.91%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: REGN

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: REGN

    Operations Margin -37.67%
    Net Profit Margin -34.69%
    Gross Profit Margin -16.98%
  • Financial Strength: REGN

    Quick Ratio (MRQ) 6.09
    Current Ratio (MRQ) 4.04
    LT Debt to Equity (MRQ) 0.00
    Total Debt to Equity (MRQ) 0.00
    Return on Equity (ROE) Per Share -18.95
    Return on Assets (ROA) -7.99
    Return on Invested Capital (ROIC) -14.40
  • Assets: REGN

    Asset Turnover 0.36
    Inventory Turnover 89.96